TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Restorative Exercise for Strength Training and Operational Resilience
Brief Summary: The purpose of the study is to learn about the effect of integrative therapies on chronic or recurrent low back pain.

The intervention called RESTORE (Restorative Exercises for Strength Training and Operational Resilience) is based on a series of gentle stretching and strengthening exercises incorporating breath-work and mindfulness. The study is designed to discover the impact of RESTORE on pain levels, physical function, and behavioral health.


Options:
A: Arm Label: Individual Cognitive Functional Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Individual Cognitive Functional Therapy | Arm Label: Group Exercise Classes; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Exercise Classes | Intervention Type: BEHAVIORAL; Name: Individual Cognitive Functional Therapy; Assigned to Arm(s): Individual Cognitive Functional Therapy | Intervention Type: BEHAVIORAL; Name: Group Exercise Classes; Assigned to Arm(s): Group Exercise Classes
B: Arm Label: BB; Type: ACTIVE_COMPARATOR; Interventions: Other: Mild, Other: Mild vs. NC | Arm Label: BB+A; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Mild, Other: Mild vs. NC, Other: Moderate vs. NC | Arm Label: DBC; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Moderate vs. NC | Arm Label: PMU; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Moderate vs. NC | Arm Label: NC; Type: PLACEBO_COMPARATOR; Interventions: Other: Mild vs. NC, Other: Moderate vs. NC | Intervention Type: OTHER; Name: Moderate; Assigned to Arm(s): BB+A, DBC, PMU | Intervention Type: OTHER; Name: Mild; Assigned to Arm(s): BB, BB+A | Intervention Type: OTHER; Name: Mild vs. NC; Assigned to Arm(s): BB, BB+A, NC | Intervention Type: OTHER; Name: Moderate vs. NC; Assigned to Arm(s): BB+A, DBC, NC, PMU
C: Arm Label: Education and Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and standard care | Arm Label: Internet Mediated Enhanced Pedometer; Type: EXPERIMENTAL; Interventions: Other: Education and standard care, Behavioral: Internet mediated enhanced pedometer intervention | Intervention Type: OTHER; Name: Education and standard care; Assigned to Arm(s): Education and Standard Care, Internet Mediated Enhanced Pedometer | Intervention Type: BEHAVIORAL; Name: Internet mediated enhanced pedometer intervention; Assigned to Arm(s): Internet Mediated Enhanced Pedometer
D: Arm Label: RESTORE Intervention; Type: EXPERIMENTAL; Interventions: Other: RESTORE Intervention | Arm Label: Control Group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: RESTORE Intervention; Assigned to Arm(s): RESTORE Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Restorative Exercise for Strength Training and Operational Resilience
Brief Summary: The purpose of the study is to learn about the effect of integrative therapies on chronic or recurrent low back pain.

The intervention called RESTORE (Restorative Exercises for Strength Training and Operational Resilience) is based on a series of gentle stretching and strengthening exercises incorporating breath-work and mindfulness. The study is designed to discover the impact of RESTORE on pain levels, physical function, and behavioral health.


Options:
A: Arm Label: RESTORE Intervention; Type: EXPERIMENTAL; Interventions: Other: RESTORE Intervention | Arm Label: Control Group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: RESTORE Intervention; Assigned to Arm(s): RESTORE Intervention
B: Arm Label: kUNDALINI YOGA; Type: EXPERIMENTAL; Interventions: Behavioral: Kundalini yoga | Arm Label: Self care advice to stay active; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self care advice | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Kundalini yoga; Assigned to Arm(s): kUNDALINI YOGA | Intervention Type: BEHAVIORAL; Name: Self care advice; Assigned to Arm(s): Self care advice to stay active | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
C: Arm Label: Yoga Class Twice Per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class twice per week | Arm Label: Yoga Class Once per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class once per week | Intervention Type: BEHAVIORAL; Name: Yoga class once per week; Assigned to Arm(s): Yoga Class Once per Week | Intervention Type: BEHAVIORAL; Name: Yoga class twice per week; Assigned to Arm(s): Yoga Class Twice Per Week
D: Arm Label: Hatha yoga; Type: EXPERIMENTAL; Interventions: Behavioral: hatha yoga | Arm Label: Health education; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: health education | Intervention Type: BEHAVIORAL; Name: hatha yoga; Assigned to Arm(s): Hatha yoga | Intervention Type: BEHAVIORAL; Name: health education; Assigned to Arm(s): Health education

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Subjects Who Are Assessed to be at Imminent Risk for Suicide
Brief Summary: The purpose of this study is to evaluate the efficacy of intranasal esketamine 84 milligram (mg) compared with intranasal placebo along with standard care treatment, in reducing the symptoms of major depressive disorder (MDD) (an affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities, the mood disturbance is prominent and relatively persistent), including the risk for suicide as assessed by the Investigator, in participants who will be assessed to be at imminent risk for suicide.


Options:
A: Arm Label: A: Ketamine + Naltrexone or placebo; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone | Arm Label: B: Ketamine + Naltrexone or placebo; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): A: Ketamine + Naltrexone or placebo, B: Ketamine + Naltrexone or placebo
B: Arm Label: Esketamine; Type: EXPERIMENTAL; Interventions: Drug: Esketamine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Esketamine; Assigned to Arm(s): Esketamine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Arm Label: Ketamine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ketamine | Intervention Type: DRUG; Name: Ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam
D: Arm Label: AZD6765 (150 mg) / Placebo; Type: EXPERIMENTAL; Interventions: Drug: AZD6765 | Arm Label: Placebo / AZD6765 (150 mg); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to AZD6765 | Intervention Type: DRUG; Name: AZD6765; Assigned to Arm(s): AZD6765 (150 mg) / Placebo | Intervention Type: DRUG; Name: Placebo to AZD6765; Assigned to Arm(s): Placebo / AZD6765 (150 mg)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Randomized Controlled Trial to Evaluate a Brief Psychosocial Intervention Together With Early Palliative Care in Reducing Depressive Symptoms of Patients With Advanced Cancer Starting First Line Palliative Chemotherapy
Brief Summary: The purpose of this study is to determine whether a brief psychosocial intervention together with early palliative care are feasible, acceptable and effective in the reduction of depressive symptoms of patients with advanced cancers starting first line palliative chemotherapy.


Options:
A: Arm Label: control; Type: PLACEBO_COMPARATOR; Interventions: Other: early palliative care | Arm Label: early palliative care; Type: ACTIVE_COMPARATOR; Interventions: Other: early palliative care | Intervention Type: OTHER; Name: early palliative care; Assigned to Arm(s): control, early palliative care
B: Arm Label: Early Palliative Care Referral; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early Palliative Care Referral | Arm Label: Conventional Cancer Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Early Palliative Care Referral | Intervention Type: BEHAVIORAL; Name: Early Palliative Care Referral; Assigned to Arm(s): Conventional Cancer Care, Early Palliative Care Referral
C: Arm Label: ENABLE (concurrent palliative care); Type: EXPERIMENTAL; Interventions: Other: counseling intervention, Other: educational intervention, Procedure: psychosocial assessment and care, Procedure: quality-of-life assessment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: counseling intervention, Procedure: psychosocial assessment and care, Procedure: quality-of-life assessment | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care | Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): ENABLE (concurrent palliative care) | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): ENABLE (concurrent palliative care), Usual Care
D: Arm Label: Standard oncologic care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Early Palliative Care; Type: EXPERIMENTAL; Interventions: Other: Early Palliative Care | Arm Label: Psychosocial plus early Palliative Care; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Psychosocial Intervention, Other: Early Palliative Care | Intervention Type: BEHAVIORAL; Name: Brief Psychosocial Intervention; Assigned to Arm(s): Psychosocial plus early Palliative Care | Intervention Type: OTHER; Name: Early Palliative Care; Assigned to Arm(s): Early Palliative Care, Psychosocial plus early Palliative Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
Brief Summary: This is a Phase 3 multicentre, randomized, double blind, placebo-controlled study to determine the effectiveness of the rotavirus vaccine.


Options:
A: Arm Label: Oral Rotavirus Vaccine 116E (ORV 116E); Type: EXPERIMENTAL; Interventions: Biological: ORV 116E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: ORV 116E; Assigned to Arm(s): Oral Rotavirus Vaccine 116E (ORV 116E) | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Group 1, RotaTeq® x 3; Type: ACTIVE_COMPARATOR; Interventions: Biological: RotaTeq® | Arm Label: Group 5, Rotarix®, RotaTeq® x2; Type: EXPERIMENTAL; Interventions: Biological: Rotarix®, Biological: RotaTeq® | Arm Label: Group 4, Rotarix® x 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Rotarix® | Arm Label: Group 2, RotaTeq®, Rotarix® x 2; Type: EXPERIMENTAL; Interventions: Biological: Rotarix®, Biological: RotaTeq® | Arm Label: Group 3, RotaTeq® x 2, Rotarix®; Type: EXPERIMENTAL; Interventions: Biological: Rotarix®, Biological: RotaTeq® | Intervention Type: BIOLOGICAL; Name: Rotarix®; Assigned to Arm(s): Group 2, RotaTeq®, Rotarix® x 2, Group 3, RotaTeq® x 2, Rotarix®, Group 4, Rotarix® x 2, Group 5, Rotarix®, RotaTeq® x2 | Intervention Type: BIOLOGICAL; Name: RotaTeq®; Assigned to Arm(s): Group 1, RotaTeq® x 3, Group 2, RotaTeq®, Rotarix® x 2, Group 3, RotaTeq® x 2, Rotarix®, Group 5, Rotarix®, RotaTeq® x2
C: Arm Label: Vaccine Arm; Type: EXPERIMENTAL; Interventions: Biological: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV) | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV); Assigned to Arm(s): Vaccine Arm | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo group
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Rotavirus Vaccine (ROTARIX) | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Rotavirus Vaccine (ROTARIX); Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
Brief Summary: This is a Phase 3 multicentre, randomized, double blind, placebo-controlled study to determine the effectiveness of the rotavirus vaccine.


Options:
A: Intervention Type: BIOLOGICAL; Name: Rotavirus (vaccine); Assigned to Arm(s): N/A
B: Arm Label: Group 1: Concomitant Administration; Type: EXPERIMENTAL; Interventions: Biological: RotaTeq®, Biological: NeisVac-C® | Arm Label: Group 2: Sequential Administration; Type: ACTIVE_COMPARATOR; Interventions: Biological: RotaTeq®, Biological: NeisVac-C® | Intervention Type: BIOLOGICAL; Name: RotaTeq®; Assigned to Arm(s): Group 1: Concomitant Administration, Group 2: Sequential Administration | Intervention Type: BIOLOGICAL; Name: NeisVac-C®; Assigned to Arm(s): Group 1: Concomitant Administration, Group 2: Sequential Administration
C: Arm Label: Vaccine Arm; Type: EXPERIMENTAL; Interventions: Biological: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV) | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV); Assigned to Arm(s): Vaccine Arm | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo group
D: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Transcranial Direct Current Stimulation (tDCS) on Locomotion and Bipedal Equilibrium in Hemiplegic Patients: a Crossover Randomized Controlled Trial
Brief Summary: The aim of this trial is to quantify the improvement of locomotion and equilibrium induced par tDCS in anode polarity position in post stroke hemiplegic patients.


Options:
A: Arm Label: tDCS plus wrist robot therapy; Type: EXPERIMENTAL; Interventions: Device: tDCS plus wrist robot therapy | Arm Label: Sham tDCS plus wrist robot therapy; Type: SHAM_COMPARATOR; Interventions: Device: Sham tDCS plus wrist robot therapy | Intervention Type: DEVICE; Name: tDCS plus wrist robot therapy; Assigned to Arm(s): tDCS plus wrist robot therapy | Intervention Type: DEVICE; Name: Sham tDCS plus wrist robot therapy; Assigned to Arm(s): Sham tDCS plus wrist robot therapy
B: Arm Label: sham and then anodal; Type: EXPERIMENTAL; Interventions: Device: anodal tDCS and sham tDCS stimulations | Arm Label: anodal and then sham; Type: EXPERIMENTAL; Interventions: Device: anodal tDCS and sham tDCS stimulations | Intervention Type: DEVICE; Name: anodal tDCS and sham tDCS stimulations; Assigned to Arm(s): anodal and then sham, sham and then anodal
C: Arm Label: Real stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Arm Label: Sham stimulation; Type: SHAM_COMPARATOR; Interventions: Device: tdcs (ELDITH, Neuroconn, Ilmenau, Germany) | Intervention Type: DEVICE; Name: tdcs (ELDITH, Neuroconn, Ilmenau, Germany); Assigned to Arm(s): Real stimulation, Sham stimulation
D: Arm Label: real-tDCS with MI-BCI; Type: ACTIVE_COMPARATOR; Interventions: Device: real-tDCS with MI-BCI | Arm Label: sham-tDCS with MI-BCI; Type: SHAM_COMPARATOR; Interventions: Device: real-tDCS with MI-BCI | Intervention Type: DEVICE; Name: real-tDCS with MI-BCI; Assigned to Arm(s): real-tDCS with MI-BCI, sham-tDCS with MI-BCI

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smartphone Application for Smoking Cessation
Brief Summary: The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.


Options:
A: Arm Label: C2Q-Teen app; Type: EXPERIMENTAL; Interventions: Behavioral: C2Q-Teen app | Arm Label: NCI's QuitSTART app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: NCI's QuitSTART app | Arm Label: Written smoking cessation materials only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written smoking cessation materials only | Intervention Type: BEHAVIORAL; Name: C2Q-Teen app; Assigned to Arm(s): C2Q-Teen app | Intervention Type: BEHAVIORAL; Name: NCI's QuitSTART app; Assigned to Arm(s): NCI's QuitSTART app | Intervention Type: BEHAVIORAL; Name: Written smoking cessation materials only; Assigned to Arm(s): Written smoking cessation materials only
B: Arm Label: ACT Group 1; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance and Commitment Therapy, Drug: Varenicline | Arm Label: MBC Group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational and Behavioral Counseling, Drug: Varenicline | Intervention Type: BEHAVIORAL; Name: Acceptance and Commitment Therapy; Assigned to Arm(s): ACT Group 1 | Intervention Type: BEHAVIORAL; Name: Motivational and Behavioral Counseling; Assigned to Arm(s): MBC Group 2 | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): ACT Group 1, MBC Group 2
C: Arm Label: Mindfulness in nature; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness | Arm Label: Mindfulness indoor; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness | Arm Label: Wait list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness; Assigned to Arm(s): Mindfulness in nature, Mindfulness indoor
D: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smartphone Application for Smoking Cessation
Brief Summary: The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.


Options:
A: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app
B: Arm Label: Facebook intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Facebook intervention | Arm Label: Referral; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smokefree.gov | Intervention Type: BEHAVIORAL; Name: Facebook intervention; Assigned to Arm(s): Facebook intervention | Intervention Type: BEHAVIORAL; Name: Smokefree.gov; Assigned to Arm(s): Referral
C: Arm Label: SMS Turkey; Type: EXPERIMENTAL; Interventions: Behavioral: SMS Turkey | Arm Label: Brochure control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS Turkey; Assigned to Arm(s): SMS Turkey
D: Arm Label: MiQuit; Type: EXPERIMENTAL; Interventions: Behavioral: MiQuit | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MiQuit; Assigned to Arm(s): MiQuit

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smartphone Application for Smoking Cessation
Brief Summary: The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.


Options:
A: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app
B: Arm Label: Standard Care plus Wellness Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Wellness Program | Arm Label: Standard Care plus Exercise Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Aerobic Exercise | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Treatment; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Wellness Program; Assigned to Arm(s): Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise; Assigned to Arm(s): Standard Care plus Exercise Program
C: Arm Label: Group Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Group Cognitive Behavioral Therapy, Drug: Transdermal Nicotine Patch | Arm Label: General Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Health Education, Drug: Transdermal Nicotine Patch | Intervention Type: BEHAVIORAL; Name: Group Cognitive Behavioral Therapy; Assigned to Arm(s): Group Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: General Health Education; Assigned to Arm(s): General Health Education | Intervention Type: DRUG; Name: Transdermal Nicotine Patch; Assigned to Arm(s): General Health Education, Group Cognitive Behavioral Therapy
D: Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Control arm (i.e: regular care) | Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist delivered smoking cessation program | Intervention Type: BEHAVIORAL; Name: Pharmacist delivered smoking cessation program; Assigned to Arm(s): Intervention arm | Intervention Type: OTHER; Name: Control arm (i.e: regular care); Assigned to Arm(s): Control arm

Answer: A